News | Health & Safety
22 Oct 2017 15:49
NZCity News
NZCity CalculatorReturn to NZCity

  • Start Page
  • Personalise
  • Sport
  • Weather
  • Olympic Games
  • Ski Report
  • Finance
  • Shopping
  • Jobs
  • Horoscopes
  • Lotto Results
  • Photo Gallery
  • Site Gallery
  • TVNow
  • Dating
  • SearchNZ
  • NZSearch
  • Crime.co.nz
  • RugbyLeague
  • Make Home
  • About NZCity
  • Contact NZCity
  • Your Privacy
  • Advertising
  • Login
  • Join for Free

  •   Home > News > Health & Safety

    Pacific Edge gets $3m extension to grant

    Pacific Edge has won a two-year extension to its research grant to fund the development of its Cxbladder products for bladder cancer detection.


    Pacific Edge has won a two-year extension to its Callaghan Innovation research grant to fund the development of its Cxbladder diagnostic suite of products for bladder cancer detection.

    The Dunedin-based firm has received up to $3 million of extra funding for research and development spread over two years, on top of an initial three-year grant of $4.5m it received in 2014, it said in a statement.

    Since the first grant was awarded, Pacific Edge has launched three new products to add to the original bladder cancer diagnostics test, with each test addressing different clinical needs.

    The shares rose 3.5 per cent to 59 cents.

    "Investment into research and development is a major focus for Pacific Edge and we are continually looking at how we can provide better and more targeted diagnostic tools for clinicians and their patients," chief executive David Darling said.

    "The Growth Grant supplements Pacific Edge's own investment into R&D and will enable us to bring new innovations through into new products and product improvements."

    The company raised $8 million in February through a share placement to institutional investors to shore up its balance sheet as it ramps up efforts to lift commercial growth.

    It started making commercial sales in 2013 and at the time was targeting $100m in gross revenue within five years.

    The recent capital raise left it with $9m of cash to fund its immediate growth needs, and when reporting its first half result in November it signalled plans to have all four Cxbladder products fully launched in the US by 2018.

    # (BusinessDesk receives funding from Callaghan Innovation to help cover the commercialisation of innovation.)


    NZN




    © 2017 NZN, NZCity


     Other Health & Safety News
     21 Oct: Woman charged over Auckland stabbing
     21 Oct: Mental health a top priority in Canterbury
     20 Oct: Shares rise as weak dollar helps companies
     20 Oct: More drinking fountains to tackle obesity
     17 Oct: Mums reminded about iodine, folic acid
     16 Oct: Man, 78, dies after four-day surgery wait
     16 Oct: Waikato DHB appoints new boss
     Top Stories

    RUGBY RUGBY
    Wallabies ready to kick on: Dempsey More...


    BUSINESS BUSINESS
    Shares rise as weak dollar helps companies More...



     Today's News

    Soccer:
    Phoenix keep eye on long-term prize 15:27

    Politics:
    Indian cartoonist Aseem Trivedi once arrested for sedition, says free speech 'not in good condition' 15:17

    Cricket:
    Black Caps need to 'play the long game' 14:37

    Accident and Emergency:
    Rescue Co-ordination Centre kept busy 14:17

    Rugby:
    Wallabies ready to kick on: Dempsey 14:07

    Law and Order:
    'I didn't want my mum to know': The men and boys arrested for being gay in Nigeria 13:27

    Law and Order:
    Man critical after assault in Hastings 13:27

    Sports:
    King through to squash semis in New York 13:17

    Law and Order:
    Missing Canadian man found 12:37

    International:
    Fat talk: Have you considered that what you say about your body could hurt others 12:27


     News Search






    Power Search


    © 2017 New Zealand City Ltd